{{Rsnum
|rsid=732609
|Gene=TPO
|Chromosome=2
|position=1496155
|Orientation=plus
|GMAF=0.4706
|Gene_s=TPO
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 40.7 | 39.8 | 19.5
| HCB | 35.0 | 47.4 | 17.5
| JPT | 24.8 | 53.1 | 22.1
| YRI | 6.1 | 46.3 | 47.6
| ASW | 19.3 | 47.4 | 33.3
| CHB | 35.0 | 47.4 | 17.5
| CHD | 39.4 | 48.6 | 11.9
| GIH | 30.7 | 50.5 | 18.8
| LWK | 10.0 | 33.6 | 56.4
| MEX | 36.2 | 39.7 | 24.1
| MKK | 9.6 | 46.2 | 44.2
| TSI | 35.3 | 50.0 | 14.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=23754668
|Title=TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations
}}

{{PMID Auto
|PMID=24420335
|Title=Genetic analysis of thyroid peroxidase (TPO) gene in patients whose hypothyroidism was found in adulthood in West Bengal, India
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}